Form EFFECT Terns Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 7, 2026 |
| Accession Number: | 0001193125-26-205352 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aktion Associates Announces Headquarters Relocation and Launch of AI-Driven Client Innovation Center in Maumee, Ohio
- TEADIT® Expands Engineered Gasket Solutions for Data Centers, Helping Operators Improve PUE and Infrastructure Reliability
- Comprehensive Wealth Management celebrates 25th years of delivering high-touch, holistic financial planning services in Seattle and nationwide
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
